* OPKO Health Inc OPK.OQ OPK.O is expected to show a
fall in
quarterly revenue when it reports results on May 7 for the
period ending March 31 2024
* The Miami Florida-based company is expected to report a
23.0% decrease in revenue to $182.99 million from $237.6 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data.The company's guidance on February 27 2024,
for the period ended March 31, was for revenue between $180.00
million and $185.00 million.
* LSEG's mean analyst estimate for OPKO Health Inc is for a
loss
of 9 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for OPKO Health
Inc
is $4.00, above its last closing price of $1.30.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 -0.09 -0.09 -0.09 Met -2.3
Sep. 30 2023 -0.09 -0.10 -0.11 Missed -10
Jun. 30 2023 -0.07 -0.07 -0.03 Beat 63.6
Mar. 31 2023 -0.08 -0.08 -0.02 Beat 73.9
Dec. -0.11 -0.11 -0.11 Met 2.9
31 2022
Sep. 30 2022 -0.08 -0.08 -0.11 Missed -31
Jun. 30 2022 0.01 0.01 -0.14 Missed -1,850
Mar. 31 2022 -0.06 -0.06 -0.08 Missed -42.9
This summary was machine generated May 4 at 00:13 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)